Sigma 1 receptor activation improves retinal structure and function in the Rho


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
05 2023
Historique:
received: 12 12 2022
revised: 17 03 2023
accepted: 27 03 2023
pmc-release: 01 05 2024
medline: 28 4 2023
pubmed: 2 4 2023
entrez: 1 4 2023
Statut: ppublish

Résumé

Retinitis pigmentosa (RP) is a group of devastating inherited retinal diseases that leads to visual impairment and oftentimes complete blindness. Currently no cure exists for RP thus research into prolonging vision is imperative. Sigma 1 receptor (Sig1R) is a promising small molecule target that has neuroprotective benefits in retinas of rapidly-degenerating mouse models. It is not clear whether Sig1R activation can provide similar neuroprotective benefits in more slowly-progressing RP models. Here, we examined Sig1R-mediated effects in the slowly-progressing Rho

Identifiants

pubmed: 37003581
pii: S0014-4835(23)00083-0
doi: 10.1016/j.exer.2023.109462
pmc: PMC10155485
mid: NIHMS1891414
pii:
doi:

Substances chimiques

Rhodopsin 9009-81-8
rho GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109462

Subventions

Organisme : NEI NIH HHS
ID : P30 EY031631
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY012830
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028103
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Références

Vision (Basel). 2016 May 09;1(1):
pubmed: 31740628
Invest Ophthalmol Vis Sci. 2011 Dec 28;52(13):9728-36
pubmed: 22110080
Mol Neurodegener. 2017 Sep 19;12(1):68
pubmed: 28927431
J Neurosci Res. 2022 Apr;100(4):1063-1083
pubmed: 35165923
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):3
pubmed: 33137196
J Biol Chem. 2011 Mar 25;286(12):10551-67
pubmed: 21224384
Exp Eye Res. 2015 Mar;132:64-72
pubmed: 25616094
Brain Res. 1996 Sep 16;733(2):219-30
pubmed: 8891305
Stem Cell Res Ther. 2019 Feb 26;10(1):68
pubmed: 30808416
Br J Pharmacol. 2003 Mar;138(5):941-9
pubmed: 12642396
Prog Retin Eye Res. 2018 Mar;63:107-131
pubmed: 29097191
Surv Ophthalmol. 1999 Jan-Feb;43(4):321-34
pubmed: 10025514
Vision Res. 2007 Mar;47(5):624-33
pubmed: 17267005
J Pharmacol Sci. 2015 Jan;127(1):17-29
pubmed: 25704014
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4545-4558
pubmed: 28877319
Neuroscience. 1998 Mar;83(2):413-28
pubmed: 9460750
Cell Death Dis. 2019 Jul 18;10(8):547
pubmed: 31320609
J Comp Neurol. 2007 Jan 10;500(2):222-38
pubmed: 17111372
J Biol Chem. 2014 Mar 28;289(13):9288-303
pubmed: 24515108
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4611-6
pubmed: 15557474
Sci Rep. 2021 Aug 11;11(1):16356
pubmed: 34381136
Vision Res. 2002 Feb;42(4):517-25
pubmed: 11853768
Mol Ther Nucleic Acids. 2016 Nov 22;5(11):e389
pubmed: 27874856
J Pharmacol Exp Ther. 1982 Nov;223(2):284-90
pubmed: 6290634
Prog Retin Eye Res. 2018 Nov;67:130-149
pubmed: 30075336
Exp Eye Res. 2002 Dec;75(6):723-30
pubmed: 12470974
Neuron. 1992 Nov;9(5):815-30
pubmed: 1418997
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
Trends Neurosci. 2013 Jul;36(7):385-95
pubmed: 23601133
Free Radic Biol Med. 2019 Apr;134:604-616
pubmed: 30743048
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):5
pubmed: 32150247
Redox Biol. 2019 Jun;24:101199
pubmed: 31026769
Trends Pharmacol Sci. 2016 Apr;37(4):262-278
pubmed: 26869505
Brain Res Mol Brain Res. 2001 Nov 1;95(1-2):86-95
pubmed: 11687279
Nat Commun. 2017 Mar 14;8:14716
pubmed: 28291770
J Clin Invest. 2020 Apr 1;130(4):2054-2068
pubmed: 32175920
Sci Rep. 2021 Nov 9;11(1):21975
pubmed: 34753986
Trends Mol Med. 2005 Apr;11(4):177-85
pubmed: 15823756
Brain. 2014 Jul;137(Pt 7):1998-2014
pubmed: 24755275
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3764-72
pubmed: 27298364
Sci Transl Med. 2011 Jun 22;3(88):88ra54
pubmed: 21697530

Auteurs

Shannon R Barwick (SR)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA. Electronic address: sbarwick@augusta.edu.

Haiyan Xiao (H)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA.

David Wolff (D)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Jing Wang (J)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA.

Elizabeth Perry (E)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Brendan Marshall (B)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Sylvia B Smith (SB)

Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH